Birzeit Pharmaceuticals Company (PEX:BPC)
Palestine · Delayed Price · Currency is JOD · Price in USD 3.710
0.00 (0.00%)
At close: Jul 8, 2026
PEX:BPC Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 49.21 | 47.96 | 40.65 | 43.13 | 47.03 | 45.47 | |
Revenue Growth (YoY) | 17.72% | 17.98% | -5.74% | -8.31% | 3.44% | 26.82% |
Cost of Revenue | 30.94 | 30.51 | 27.46 | 28.16 | 30.13 | 28.14 |
Gross Profit | 18.27 | 17.45 | 13.19 | 14.97 | 16.91 | 17.33 |
Selling, General & Admin | 7.04 | 6.52 | 5.55 | 6.94 | 7.13 | 6.84 |
Operating Expenses | 7.26 | 6.73 | 5.55 | 7.79 | 7.35 | 7.01 |
Operating Income | 11.01 | 10.72 | 7.64 | 7.18 | 9.56 | 10.31 |
Interest Expense | -0.06 | -0.05 | -0.03 | -0.09 | -0.11 | -0.2 |
Interest & Investment Income | 0.04 | 0.04 | 0.04 | - | - | - |
Currency Exchange Gain (Loss) | 2.63 | 1.87 | -0.27 | -0.34 | -1.91 | 0.05 |
Other Non Operating Income (Expenses) | 0 | 0.01 | 0.1 | 0.26 | 0.12 | 0.09 |
EBT Excluding Unusual Items | 13.62 | 12.59 | 7.48 | 7 | 7.67 | 10.26 |
Gain (Loss) on Sale of Investments | -0.28 | - | - | -0.06 | 2.05 | 2.69 |
Gain (Loss) on Sale of Assets | 0.5 | 0.5 | -1.43 | 0.05 | - | 0.16 |
Asset Writedown | - | - | - | - | -0.69 | 0.27 |
Pretax Income | 13.84 | 13.08 | 6.06 | 7 | 9.02 | 13.38 |
Income Tax Expense | 1.22 | 1.17 | 0.87 | 0.85 | 1.09 | 1.21 |
Earnings From Continuing Operations | 12.61 | 11.91 | 5.19 | 6.15 | 7.93 | 12.17 |
Minority Interest in Earnings | -0.02 | 0.04 | -0 | -0.04 | 0.01 | -0.09 |
Net Income | 12.59 | 11.95 | 5.18 | 6.12 | 7.95 | 12.08 |
Net Income to Common | 12.59 | 11.95 | 5.18 | 6.12 | 7.95 | 12.08 |
Net Income Growth | 58.16% | 130.54% | -15.26% | -23.05% | -34.21% | 63.91% |
Shares Outstanding (Basic) | 39 | 39 | 39 | 39 | 38 | 39 |
Shares Outstanding (Diluted) | 39 | 39 | 39 | 39 | 38 | 39 |
Shares Change (YoY) | - | - | - | 2.30% | -2.38% | - |
EPS (Basic) | 0.33 | 0.31 | 0.13 | 0.16 | 0.21 | 0.31 |
EPS (Diluted) | 0.33 | 0.31 | 0.13 | 0.16 | 0.21 | 0.31 |
EPS Growth | 58.16% | 130.54% | -15.26% | -24.77% | -32.60% | 63.91% |
Free Cash Flow | 0.89 | 0 | 5.43 | 8.83 | 1.62 | 2.72 |
Free Cash Flow Per Share | 0.02 | - | 0.14 | 0.23 | 0.04 | 0.07 |
Dividend Per Share | 0.050 | 0.050 | 0.050 | 0.050 | 0.100 | 0.050 |
Dividend Growth | - | - | - | -50.00% | 100.00% | -31.97% |
Gross Margin | 37.12% | 36.38% | 32.45% | 34.71% | 35.94% | 38.11% |
Operating Margin | 22.37% | 22.35% | 18.80% | 16.65% | 20.32% | 22.68% |
Profit Margin | 25.58% | 24.91% | 12.75% | 14.18% | 16.90% | 26.56% |
Free Cash Flow Margin | 1.81% | 0.01% | 13.37% | 20.47% | 3.44% | 5.98% |
EBITDA | 12.42 | 12.13 | 9.06 | 8.68 | 11.22 | 11.98 |
EBITDA Margin | 25.23% | 25.29% | 22.28% | 20.12% | 23.85% | 26.34% |
D&A For EBITDA | 1.41 | 1.41 | 1.42 | 1.5 | 1.66 | 1.66 |
EBIT | 11.01 | 10.72 | 7.64 | 7.18 | 9.56 | 10.31 |
EBIT Margin | 22.37% | 22.35% | 18.80% | 16.65% | 20.32% | 22.68% |
Effective Tax Rate | 8.85% | 8.97% | 14.35% | 12.09% | 12.07% | 9.05% |
Advertising Expenses | - | 0.08 | 0.07 | 1.28 | - | 0.11 |